Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/7631| The SARS-CoV2 pandemic and routine immunisation | |
| Gagandeep Kang | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| https://doi.org/10.1016/S2214-109X(21)00543-X | |
| https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00543-X/fulltext#articleInformation | |
| In May, 2012, the Global Vaccine Action Plan (GVAP) was endorsed at the World Health Assembly by the 194 member states. The GVAP was intended as a framework to promote high and equitable access to vaccines by 2020, helping save millions of children's lives. The plan had five goals, comprising the eradication of poliomyelitis, the elimination of measles and rubella, achieving high vaccine coverage across and within countries, the introduction of new vaccines into low-income and middle-income countries (LMICs), and the reduction of mortality. Although some progress was made towards all goals, only one was achieved. Gavi, the Vaccine Alliance and immunisation partners supported eligible LMICs to introduce a range of vaccines available in high-income countries, but not used elsewhere. In addition to the introduction of vaccines, the GVAP monitoring framework showed that there was progress in many countries, and that regular engagement at country, regional, and global levels maintained immunisation coverage among children at 86% of the third dose of diphtheria–pertussis–tetanus-containing vaccine | |
| The Lancet Global Health | |
| 27-01-2022 | |
| Reseña crítica | |
| https://www.thelancet.com | |
| Inglés | |
| Epidemia COVID-19 | |
| Público en general | |
| VIRUS RESPIRATORIOS | |
| Versión publicada | |
| publishedVersion - Versión publicada | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| The SARS COV2 pandemic and routine immunisation.pdf | 48.64 kB | Adobe PDF | Visualizar/Abrir |